The Pros & Cons of Combining Different Specialties Under One Roof

References

Gallegos A. Combined dermatology-rheumatology clinics improve care, spark new research. Rheumatology News. 2015 Oct 16.
Soleymani T, Reddy SM, Cohen JM, Neiman AL. Early recognition and treatment heralds optimal outcomes: The benefits of combined rheumatology-dermatology clinics and integrative care of psoriasis and psoriatic arthritis patients. Curr Rheumatol Rep. 2017 Nov20;20(1):1.
McNamara D. Benefits, challenges emerge in the evolution of the rheumatology-dermatology clinics. Dermatology News. 2016 Jul 21.
Cobo-Ibáñez T, Villaverde V, Seoane-Mato D, et al. Multidisciplinary dermatology-rheumatology management for patients with moderate to severe psoriasis and psoriatic arthritis: A systematic review. Rheumatol Int. 2016 Feb;36(2):221–229.
Samycia M, McCourt C, Shojania K, et al. Experiences from a combined dermatology and rheumatology clinic: A retrospective review. J Cutan Med Surg. 2016 Sep;20(5):486–489.

Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)

No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

Introduction The understanding and treatment of rheumatoid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

References

What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

A Rheumatologist & Pulmonologist Discuss RA-ILD

References

Related Articles